Fluphenazine-induced parkinsonism in the baboon: pharmacological and metabolic studies.
D000818:Animals; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000188:drug therapy; D001590:Benztropine / Q000627:therapeutic use; D002247:Carbon Isotopes; D002855:Chromatography, Thin Layer; D005243:Feces / Q000032:analysis; D005260:Female; D005476:Fluphenazine / Q000008:administration & dosage / Q000032:analysis / Q000097:blood / Q000494:pharmacology* / Q000652:urine; D006207:Half-Life; D000882:Haplorhini / Q000502:physiology*; D010215:Papio; D010300:Parkinson Disease / Q000188:drug therapy; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D014282:Trihexyphenidyl / Q000627:therapeutic use
D002247:Carbon Isotopes; D001590:Benztropine; D014282:Trihexyphenidyl; D005476:Fluphenazine